SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950116-04-000936
Filing Date
2004-03-24
Accepted
2004-03-24 16:56:50
Documents
6
Period of Report
2004-01-05
Items
Item 5: Other events

Document Format Files

Seq Description Document Type Size
1 8-K/A eightka.txt 8-K/A 4273
3 EXHIBIT 4.1 ex4-1.txt EX-4 76866
4 EXHIBIT 4.2 ex4-2.txt EX-4 59509
5 EXHIBIT 4.3 ex4-3.txt EX-4 34718
6 EXHIBIT 4.4 ex4-4.txt EX-4 38353
7 EXHIBIT 99.1 ex99-1.txt EX-99 4025
  Complete submission text file 0000950116-04-000936.txt   219828
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-25169 | Film No.: 04687801
SIC: 2834 Pharmaceutical Preparations